Your browser doesn't support javascript.
loading
Description of hypersensitivity adverse events following administration of heparin that was potentially contaminated with oversulfated chondroitin sulfate in early 2008.
McMahon, Ann W; Pratt, Robert G; Hammad, Tarek A; Kozlowski, Steven; Zhou, Esther; Lu, Susan; Kulick, Corrinne G; Mallick, Tarun; Dal Pan, Gerald.
Affiliation
  • McMahon AW; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD 20993, USA. ann.mcmahon@fda.hhs.gov
Pharmacoepidemiol Drug Saf ; 19(9): 921-33, 2010 Sep.
Article in En | MEDLINE | ID: mdl-20661880
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Chondroitin Sulfates / Drug Hypersensitivity / Anticoagulants Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Heparin / Chondroitin Sulfates / Drug Hypersensitivity / Anticoagulants Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Aged80 / Child / Child, preschool / Female / Humans / Male / Middle aged Country/Region as subject: America do norte Language: En Journal: Pharmacoepidemiol Drug Saf Journal subject: EPIDEMIOLOGIA / TERAPIA POR MEDICAMENTOS Year: 2010 Document type: Article Affiliation country: Country of publication: